Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses
- PMID: 33505989
- PMCID: PMC7832476
- DOI: 10.3389/fmolb.2020.611017
Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses
Abstract
Vitreoretinal lymphoma (VRL) is a rare ocular malignancy that manifests as diffuse large B-cell lymphoma. Early and accurate diagnosis is essential to prevent mistreatment and to reduce the high morbidity and mortality associated with VRL. The disease can be diagnosed using various methods, including cytology, immunohistochemistry, cytokine analysis, flow cytometry, and molecular analysis of bulk vitreous aspirates. Despite these options, VRL diagnosis remains challenging, as samples are often confounded by low cellularity, the presence of debris and non-target immunoreactive cells, and poor cytological preservation. As such, VRL diagnostic accuracy is limited by both false-positive and false-negative outcomes. Missed or inappropriate diagnosis may cause delays in treatment, which can have life-threatening consequences for patients with VRL. In this review, we summarize current knowledge and the diagnostic modalities used for VRL diagnosis. We also highlight several emerging molecular techniques, including high-resolution single cell-based analyses, which may enable more comprehensive and precise VRL diagnoses.
Keywords: cytology; diffuse large B-cell lymphoma; molecular diagnostics; precision medicine; single-cell analysis; vitreoretinal lymphoma.
Copyright © 2021 Tan, Wang, Ricciardi-Castagnoli, Chan and Lim.
Conflict of interest statement
WJT and TSL were employees and PR-C a consultant for A. Menarini Biomarkers Singapore Pte Ltd. ASYC received research funding from A. Menarini Biomarkers Singapore Pte Ltd. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.Ophthalmology. 2021 Jul;128(7):1079-1090. doi: 10.1016/j.ophtha.2020.11.018. Epub 2020 Nov 20. Ophthalmology. 2021. PMID: 33221324
-
Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.Oncotarget. 2017 Jan 31;8(5):7989-7998. doi: 10.18632/oncotarget.14008. Oncotarget. 2017. PMID: 28002793 Free PMC article.
-
PreservCyt Is an Optimal Fixative that Permits Cytologic and Molecular Analyses of Vitreoretinal Lymphoma Biopsies.Ocul Immunol Inflamm. 2021 Apr 3;29(3):430-439. doi: 10.1080/09273948.2019.1636093. Epub 2019 Aug 16. Ocul Immunol Inflamm. 2021. PMID: 31418635
-
Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches.Prog Retin Eye Res. 2022 Sep;90:101053. doi: 10.1016/j.preteyeres.2022.101053. Epub 2022 Feb 21. Prog Retin Eye Res. 2022. PMID: 35210172 Review.
-
Clinical guidelines for the diagnosis and treatment of vitreoretinal lymphoma in Chinese patients (2024).Eye Vis (Lond). 2025 May 26;12(1):20. doi: 10.1186/s40662-025-00434-4. Eye Vis (Lond). 2025. PMID: 40414948 Free PMC article. Review.
Cited by
-
Deep sequencing as a diagnostic tool in patients with suspected primary vitreoretinal lymphoma.Br J Ophthalmol. 2024 Dec 17;109(1):70-75. doi: 10.1136/bjo-2023-324769. Br J Ophthalmol. 2024. PMID: 39122354 Free PMC article.
-
Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools.Curr Oncol. 2022 Sep 24;29(10):6908-6921. doi: 10.3390/curroncol29100543. Curr Oncol. 2022. PMID: 36290820 Free PMC article. Review.
-
The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit.Ocul Oncol Pathol. 2023 Sep;9(3-4):71-95. doi: 10.1159/000530730. Epub 2023 Apr 18. Ocul Oncol Pathol. 2023. PMID: 37900189 Free PMC article. No abstract available.
-
Molecular diagnosis of vitreoretinal lymphoma.Taiwan J Ophthalmol. 2024 Dec 24;15(2):236-244. doi: 10.4103/tjo.TJO-D-24-00052. eCollection 2025 Apr-Jun. Taiwan J Ophthalmol. 2024. PMID: 40584202 Free PMC article. Review.
-
Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis.Front Oncol. 2022 Aug 18;12:955080. doi: 10.3389/fonc.2022.955080. eCollection 2022. Front Oncol. 2022. PMID: 36059608 Free PMC article.
References
-
- Alas S., Bonavida B. (2001). Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res. 61, 5137–5144. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials